Search research articles
Contact Us
Filters
Showing results (1241-1250 of 1,558) with videos related to
Page
of 156
Sort By:
Circulation. Cardiovascular Quality and Outcomes
|
July 29, 2010
Do major cardiovascular outcomes in patients with stable ischemic heart disease in the clinical outcomes utilizing revascularization and aggressive drug evaluation trial differ by healthcare system?
Bernard R Chaitman, Pamela M Hartigan, David C Booth, et al.
Journal of the American College of Cardiology
|
July 2, 2011
Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial
David J Maron, William E Boden, John A Spertus, et al.
The Journal of Investigative Dermatology
|
November 10, 2021
Deep Learning and Pathomics Analyses Reveal Cell Nuclei as Important Features for Mutation Prediction of BRAF-Mutated Melanomas
Randie H Kim, Sofia Nomikou, Nicolas Coudray, et al.
Circulation. Cardiovascular Imaging
|
September 20, 2022
Deep Learning for Explainable Estimation of Mortality Risk From Myocardial Positron Emission Tomography Images
Ananya Singh, Jacek Kwiecinski, Robert J H Miller, et al.
Journal of Cardiovascular Computed Tomography
|
April 7, 2019
Validation of the Coronary Artery Calcium Data and Reporting System (CAC-DRS): Dual importance of CAC score and CAC distribution from the Coronary Artery Calcium (CAC) consortium
Omar Dzaye, Ramzi Dudum, Mohammadhassan Mirbolouk, et al.
Journal of the American College of Cardiology
|
October 15, 2021
Modeling the Recommended Age for Initiating Coronary Artery Calcium Testing Among At-Risk Young Adults
Omar Dzaye, Alexander C Razavi, Zeina A Dardari, et al.
The American Journal of Cardiology
|
July 7, 2009
Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial)
William E Boden, Robert A O'Rourke, Koon K Teo, et al.
The American Journal of Cardiology
|
October 6, 2009
Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial
David J Maron, John A Spertus, G B John Mancini, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
September 24, 2016
Prognostic significance of blood pressure response during vasodilator stress Rb-82 positron emission tomography myocardial perfusion imaging
Bradley Witbrodt, Abhinav Goyal, Anita A Kelkar, et al.
Circulation. Cardiovascular Interventions
|
November 3, 2011
Angiographic disease progression and residual risk of cardiovascular events while on optimal medical therapy: observations from the COURAGE Trial
G B John Mancini, Pamela M Hartigan, Eric R Bates, et al.
Page
of 156
Search research articles
Search
Showing results (1241-1250 of 1,558) with videos related to
Sort By:
Page
of 156
Circulation. Cardiovascular Quality and Outcomes
|
July 29, 2010
Do major cardiovascular outcomes in patients with stable ischemic heart disease in the clinical outcomes utilizing revascularization and aggressive drug evaluation trial differ by healthcare system?
Bernard R Chaitman, Pamela M Hartigan, David C Booth, et al.
Journal of the American College of Cardiology
|
July 2, 2011
Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial
David J Maron, William E Boden, John A Spertus, et al.
The Journal of Investigative Dermatology
|
November 10, 2021
Deep Learning and Pathomics Analyses Reveal Cell Nuclei as Important Features for Mutation Prediction of BRAF-Mutated Melanomas
Randie H Kim, Sofia Nomikou, Nicolas Coudray, et al.
Circulation. Cardiovascular Imaging
|
September 20, 2022
Deep Learning for Explainable Estimation of Mortality Risk From Myocardial Positron Emission Tomography Images
Ananya Singh, Jacek Kwiecinski, Robert J H Miller, et al.
Journal of Cardiovascular Computed Tomography
|
April 7, 2019
Validation of the Coronary Artery Calcium Data and Reporting System (CAC-DRS): Dual importance of CAC score and CAC distribution from the Coronary Artery Calcium (CAC) consortium
Omar Dzaye, Ramzi Dudum, Mohammadhassan Mirbolouk, et al.
Journal of the American College of Cardiology
|
October 15, 2021
Modeling the Recommended Age for Initiating Coronary Artery Calcium Testing Among At-Risk Young Adults
Omar Dzaye, Alexander C Razavi, Zeina A Dardari, et al.
The American Journal of Cardiology
|
July 7, 2009
Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial)
William E Boden, Robert A O'Rourke, Koon K Teo, et al.
The American Journal of Cardiology
|
October 6, 2009
Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial
David J Maron, John A Spertus, G B John Mancini, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
September 24, 2016
Prognostic significance of blood pressure response during vasodilator stress Rb-82 positron emission tomography myocardial perfusion imaging
Bradley Witbrodt, Abhinav Goyal, Anita A Kelkar, et al.
Circulation. Cardiovascular Interventions
|
November 3, 2011
Angiographic disease progression and residual risk of cardiovascular events while on optimal medical therapy: observations from the COURAGE Trial
G B John Mancini, Pamela M Hartigan, Eric R Bates, et al.
Page
of 156